[1]
|
R. Constantinescu and H. Zetterberg, “Urate as a Marker of Development and Progression in Parkinson’s Disease,” Drugs Today, Vol. 47, No. 5, 2011, pp. 369-380.
|
[2]
|
P. Fuhua, D. Xuhui, Z. Zhiyang, J. Ying, Y. Yu, T. Feng, L. Jia, G. Lijia and H. Xueqiang, “Antioxidant Status of Bilirubin and Uric Acid in Patients with Myasthenia Gravis,” Neuroimmunomodulation, Vol. 19, No. 1, 2012, pp. 43-49. doi:10.1159/000327727
|
[3]
|
A. Taniguchi and N. Kamatani, “Control of Renal Uric Acid Excretion and Gout,” Current Opinion in Rheumatology, Vol. 20, No. 2, 2008, pp. 192-197.
doi:10.1097/BOR.0b013e3282f33f87
|
[4]
|
M. Hamburger, H. S. Baraf, T. C. Adamson, J. Basile, L. Bass, B. Cole, P. P. Doghramji, G. A. Guadagnoli, F. Hamburger and R. Harford, “2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia,” The Physician and Sportsmedicine, Vol. 39, No. 4, 2011, pp. 98-123. doi:10.3810/psm.2011.11.1946
|
[5]
|
H. M. Lai, C. J. Chen, B. Y. Su, Y. C. Chen, S. F. Yu, J. H. Yen, M. C. Hsieh, T. T. Cheng and S. J. Chang, “Gout and Type 2 Diabetes Have a Mutual Inter-Dependent Effect on Genetic Risk Factors and Higher Incidences,” Rheumatology (Oxford), Vol. 51, No. 4, 2011, pp. 715-720.
|
[6]
|
F. Viazzi, G. Leoncini and R. Pontremoli, “Cardiovascular and Renal Effects of Hyperuricaemia and Gout,” Reumatismo, Vol. 63, No. 4, 2012, pp. 253-262.
doi:10.4081/reumatismo.2011.253
|
[7]
|
R. J. Johnson, M. A. Lanaspa and E. A. Gaucher, “Uric Acid: A Danger Signal from the RNA World that May Have a Role in the Epidemic of Obesity, Metabolic Syndrome, and Cardiorenal Disease: Evolutionary Considerations,” Seminars in Nephrology, Vol. 31, No. 5, 2011, pp. 394-399. doi:10.1016/j.semnephrol.2011.08.002
|
[8]
|
A. Enomoto, H. Kimura, A. Chairoungdua, Y. Shigeta, P. Jutabha, S. H. Cha, M. Hosoyamada, M. Takeda, T. Sekine and T. Igarashi, “Molecular Identification of a Renal Urate Anion Exchanger that Regulates Blood Urate Levels,” Nature, Vol. 417, No. 6887, 2002, pp. 447-452.
|
[9]
|
T. Kimura, S. Amonpatumrat, A. Tsukada, T. Fukutomi, P. Jutabha, T. Thammapratip, E. J. Lee, K. Ichida, N. Anzai and H. Sakurai, “Increased Expression of SLC2A9 Decreases Urate Excretion from the Kidney,” Nucleosides Nucleotides Nucleic Acids, Vol. 30, No. 12, 2011, pp. 1295-1301. doi:10.1080/15257770.2011.628354
|
[10]
|
K. Ichida, “What Lies behind Serum Urate Concentration? Insights from Genetic and Genomic Studies,” Genome Medicine, Vol. 1, No. 12, 2009, p. 118. doi:10.1186/gm118
|
[11]
|
A. So and B. Thorens, “Uric Acid Transport and Disease,” Journal of Clinical Investigation, Vol. 120, No. 6, 2010, pp. 1791-1799. doi:10.1172/JCI42344
|
[12]
|
N. Anzai and H. Endou, “Urate Transporters: An Evolving Field,” Seminars in Nephrology, Vol. 31, No. 5, 2011, pp. 400-409. doi:10.1016/j.semnephrol.2011.08.003
|
[13]
|
M. A. Hediger, R. J. Johnson, H. Miyazaki and H. Endou, “Molecular Physiology of Urate Transport,” Physiology (Bethesda), Vol. 20, No. 2, 2005, pp. 125-133.
|
[14]
|
M. Doshi, Y. Takiue, H. Saito and M. Hosoyamada, “The Increased Protein Level of URAT1 Was Observed in Obesity/Metabolic Syndrome Model Mice,” Nucleosides Nucleotides Nucleic Acids, Vol. 30, No. 12, 2011, pp. 1290-1294. doi:10.1080/15257770.2011.603711
|
[15]
|
Z. Miao, S. Yan, J. Wang, B. Wang, Y. Li, X. Xing, Y. Yuan, D. Meng, L. Wang and J. Gu, “Insulin Resistance Acts as an Independent Risk Factor Exacerbating High-Purine Diet Induced Renal Injury and Knee Joint Gouty Lesions,” Inflammation Research, Vol. 58, No. 10, 2009, pp. 659-668. doi:10.1007/s00011-009-0031-9
|
[16]
|
T. M. Coimbra, U. Janssen, H. J. Grone, T. Ostendorf, U. Kunter, H. Schmidt, G. Brabant and J. Floege, “Early Events Leading to Renal Injury in Obese Zucker (Fatty) Rats with Type II Diabetes,” Kidney International, Vol. 57, No. 1, 2000, pp. 167-182.
doi:10.1046/j.1523-1755.2000.00836.x
|
[17]
|
P. N. Chander, O. Gealekman, S. V. Brodsky, S. Elitok, A. Tojo, M. Crabtree, S. S. Gross and M. S. Goligorsky, “Nephropathy in Zucker Diabetic Fat Rat Is Associated with Oxidative and Nitrosative Stress: Prevention by Chronic Therapy with a Peroxynitrite Scavenger Ebselen,” Journal of the American Society of Nephrology, Vol. 15, No. 9, 2004, pp. 2391-2403.
doi:10.1097/01.ASN.0000135971.88164.2C
|
[18]
|
E. Ionescu, J. F. Sauter and B. Jeanrenaud, “Abnormal Oral Glucose Tolerance in Genetically Obese (Fa/Fa) Rats,” American Journal of Physiology, Vol. 248, No. 5, 1985, pp. 500-506.
|
[19]
|
M. Hosoyamada, Y. Takiue, T. Shibasaki and H. Saito, “The Effect of Testosterone upon the Urate Reabsorptive Transport System in Mouse Kidney,” Nucleosides Nucleotides Nucleic Acids, Vol. 29, No. 7, 2010, pp. 574-579. doi:10.1080/15257770.2010.494651
|
[20]
|
Y. Takiue, M. Hosoyamada, M. Kimura and H. Saito, “The Effect of Female Hormones upon Urate Transport Systems in the Mouse Kidney,” Nucleosides Nucleotides Nucleic Acids, Vol. 30, No. 2, 2011, pp.113-119.
doi:10.1080/15257770.2010.551645
|
[21]
|
Y. Slyvka, S. R. Inman, R. Malgor, E. J. Jackson, J. Yee, O. Oshogwemoh, J. Adame and F. V. Nowak, “Protective Effects of Antioxidant-Fortified Diet on Renal Function and Metabolic Profile in Obese Zucker Rat,” Endocrine, Vol. 35, No. 1, 2009, pp. 89-100.
doi:10.1007/s12020-008-9121-7
|
[22]
|
V. Tugcu, M. Bas, E. Ozbek, E. Kemahli, Y. V. Arinci, M. Tuhri, T. Altug and A. I. Tasci, “Pyrolidium Dithiocarbamate Prevents Shockwave Lithotripsy-Induced Renal Injury through Inhibition of Nuclear Factor-Kappa B and Inducible Nitric Oxide Synthase Activity in Rats,” Journal of Endourology, Vol. 22, No. 3, 2008, pp. 559-566. doi:10.1089/end.2007.0295
|
[23]
|
A. J. Collins, R. N. Foley, B. Chavers, D. Gilbertson, C. Herzog, K. Johansen, B. Kasiske, N. Kutner, J. Liu and W. Peter, “United States Renal Data System 2011 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States,” American Journal of Kidney Diseases, 2012, Vol. 59, Suppl. 1, pp. 1-420.
|
[24]
|
T. Gibson, “Hyperuricemia, Gout and the Kidney,” Current Opinion in Rheumatology, Vol. 24, No. 2, 2012, pp. 127-131. doi:10.1097/BOR.0b013e32834f049f
|
[25]
|
S. A. Eraly, V. Vallon, T. Rieg, J. A. Gangoiti, W. R. Wikoff, G. Siuzdak, B. A. Barshop and S. K. Nigam, “Multiple Organic Anion Transporters Contribute to Net Renal Excretion of Uric Acid,” Physiological Genomics, Vol. 33, No. 2, 2008, pp. 180-192.
doi:10.1152/physiolgenomics.00207.2007
|
[26]
|
G. Calabrese, H. A. Simmonds, J. S. Cameron and P. M. Davies, “Precocious Familial Gout with Reduced Fractional Urate Clearance and Normal Purine Enzymes,” The Quarterly Journal of Medicine, Vol. 75, No. 277, 1990, pp. 441-450.
|
[27]
|
N. Anzai, P. Jutabha, S. Amonpatumrat-Takahashi and H. Sakurai, “Recent Advances in Renal Urate Transport: Characterization of Candidate Transporters Indicated by Genome-Wide Association Studies,” Clinical and Experimental Nephrology, Vol. 16, No. 1, 2012, pp. 89-95.
doi:10.1007/s10157-011-0532-z
|
[28]
|
H. J. Shin, M. Takeda, A. Enomoto, M. Fujimura, H. Miyazaki, N. Anzai and H. Endou, “Interactions of Urate Transporter URAT1 in Human Kidney with Uricosuric Drugs,” Nephrology (Carlton), Vol. 16, No. 2, 2011, pp. 156-162. doi:10.1111/j.1440-1797.2010.01368.x
|
[29]
|
E. T. de Lemos, F. Reis, S. Baptista, R. Pinto, B. Sepodes, H. Vala, P. Rocha-Pereira, G. C. da Silva, N. Teixeira and A. S. Silva, “Exercise Training Decreases Proinflammatory Profile in Zucker Diabetic (Type 2) Fatty Rats,” Nutrition, Vol. 25, No. 3, 2009, pp. 330-339.
doi:10.1016/j.nut.2008.08.014
|
[30]
|
Y. Li, Y. Qi, M. S. Kim, K. Z. Xu, T. H. Huang, X. Rong, M. Murray and J. Yamahara, “Increased Renal Collagen Cross-Linking and Lipid Accumulation in Nephropathy of Zucker Diabetic Fatty Rats,” Diabetes/Metabolism Research and Reviews, Vol. 24, No. 6, 2008, pp. 498-506.
doi:10.1002/dmrr.874
|
[31]
|
M. Hosoyamada, K. Ichida, A. Enomoto, T. Hosoya and H. Endou, “Function and Localization of Urate Transporter 1 in Mouse Kidney,” Journal of the American Society of Nephrology, Vol. 15, No. 2, 2004, pp. 261-268.
doi:10.1097/01.ASN.0000107560.80107.19
|
[32]
|
F. Zhou and G. You, “Molecular Insights into the Structure-Function Relationship of Organizanion Transporters OATs,” Pharmaceutical Research, Vol. 24, No. 1, 2007, pp. 28-36. doi:10.1007/s11095-006-9144-9
|
[33]
|
N. Anzai, Y. Kanai and H. Endou, “Organic Anion Transporter Family: Current Knowledge,” Journal of Pharmacological Sciences, Vol. 100, No. 5, 2006, pp. 411-426.
doi:10.1254/jphs.CRJ06006X
|
[34]
|
K. Kuze, P. Graves, A. Leahy, P. Wilson, H. Stuhlmann and G. You, “Heterologous Expression and Functional Characterization of a Mouse Renal Organic Anion Transporter in Mammalian Cells,” The Journal of Biological Chemistry, Vol. 274, No. 3, 1999, pp. 1519-1524.
doi:10.1074/jbc.274.3.1519
|
[35]
|
K. Tanaka, W. Xu, F. Zhou and G. You, “Role of Glycosylation in the Organic Anion Transporter OAT1,” The Journal of Biological Chemistry, Vol. 79, No. 15, 2004, pp. 14961-14966. doi:10.1074/jbc.M400197200
|
[36]
|
M. Sato, T. Wakayama, H. Mamada, Y. Shirasaka, T. Nakanishi and I. Tamai, “Identification and Functional Characterization of Uric Acid Transporter Urat1 (Slc22a12) in Rats,” Biochimica et Biophysica Acta, Vol. 1808, No. 6, 2011, pp. 1441-1447. doi:10.1016/j.bbamem.2010.11.002
|
[37]
|
A. Sanchez-Pla, F. Reverter, M. C. R. de Villa and M. Comabella, “Transcriptomics: mRNA and Alternative Splicing,” Journal of Neuroimmunology, Vol. 248, No. 1-2, 2012, pp. 23-31.
|
[38]
|
M. Montes, S. Becerra, M. Sanchez-Alvarez and C. Sune, “Functional Coupling of Transcription and Splicing,” Gene, Vol. 501, No. 2, 2012, pp. 104-117.
doi:10.1016/j.gene.2012.04.006
|
[39]
|
S. Cirrik, B. U. Yavuzer and G. Oner, “Exercise-Induced Changes in Renal Urat1 Activity and Expression in Rats,” Renal Failure, Vol. 32, No. 7, 2010, pp. 855-862.
doi:10.3109/0886022X.2010.494805
|
[40]
|
C. N. Niland, C. R. Merry and A. M. Khalil, “Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders,” Frontiers in Genetics, Vol. 3, No. 3, 2012, p. 25.
|